[ARS] ENDRA Life Sciences Inc. SEC Filing

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

ARS

Rhea-AI Filing Summary

Analyzing...

10/28/2025 - 07:10 AM

Source: View Original Filing on SEC EDGAR

Endra Life Sciences Inc

NASDAQ:NDRA

NDRA Rankings

#6592 Ranked by Market Cap

N/A Ranked by Dividends

#140 Top Loser

NDRA Latest News

Dec 4, 2025

ENDRA’s TAEUS® Liver Matches MRI-PDFF Performance at Key Clinical Thresholds, Positioning Device for MASLD/MASH Trial Use

Nov 20, 2025

ENDRA Feasibility Study Demonstrates TAEUS® Accurately Quantifies Liver Fat Fraction, a Key MASLD/MASH Biomarker

Nov 17, 2025

ENDRA Life Sciences Recaps Major Milestones and New Strategic Initiatives, Announces Third Quarter 2025 Financial Results

Nov 13, 2025

ENDRA Life Sciences Commences Staking of HYPE Digital Asset Holdings, Reinforcing Long-Term Strategy with Anchorage Digital and ARCA

Oct 23, 2025

ENDRA Life Sciences Closes Up to $14.4 Million Private Placement and Launches Crypto Treasury Strategy with $3 Million in Initial HYPE Token Holdings

NDRA Latest SEC Filings

Dec 12, 2025

[8-K] ENDRA Life Sciences Inc. Reports Material Event

Nov 26, 2025

[424B4] ENDRA Life Sciences Inc. Prospectus Filed Pursuant to Rule 424(b)(4)

Nov 14, 2025

[8-K] ENDRA Life Sciences Inc. Reports Material Event

Nov 14, 2025

[10-Q] ENDRA Life Sciences Inc. Quarterly Earnings Report

Nov 6, 2025

[S-3] ENDRA Life Sciences Inc. Shelf Registration Statement

NDRA Stock Data

Market Cap 5.58M

Float 903.47k

Insiders Ownership 2.25%

Institutions Ownership 0.63%

Short Percent 13.65%

Industry Diagnostics & Research

Sector Electromedical & Electrotherapeutic Apparatus

Website Link

Country United States

City ANN ARBOR